title: Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan.
authors.affiliation: Brigham and Women's Hospital, Boston, MA.
authors.forename: Brian
authors.initials: B
authors.lastname: Claggett
authors.forename: Milton
authors.initials: M
authors.lastname: Packer
authors.forename: John J V
authors.initials: JJ
authors.lastname: McMurray
authors.forename: Karl
authors.initials: K
authors.lastname: Swedberg
authors.forename: Jean
authors.initials: J
authors.lastname: Rouleau
authors.forename: Michael R
authors.initials: MR
authors.lastname: Zile
authors.forename: Pardeep
authors.initials: P
authors.lastname: Jhund
authors.forename: Martin
authors.initials: M
authors.lastname: Lefkowitz
authors.forename: Victor
authors.initials: V
authors.lastname: Shi
authors.forename: Scott D
authors.initials: SD
authors.lastname: Solomon
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000613:Aminobutyrates / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D002423:Cause of Death; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D053208:Kaplan-Meier Estimate; D008017:Life Expectancy; D008875:Middle Aged; D013777:Tetrazoles / Q000627:therapeutic use*; D000068756:Valsartan / Q000627:therapeutic use
chemical_list: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D004338:Drug Combinations; D013777:Tetrazoles; D000068756:Valsartan; C549068:sacubitril and valsartan sodium hydrate drug combination